Trademark: 79086898
Word
MPRINT
Status Date
Sunday, April 19, 2020
Registration Number
4008175
Registration Date
Tuesday, August 9, 2011
Filing Date
Monday, April 19, 2010
Published for Opposition
Tuesday, May 24, 2011
Cancellation Date
Sunday, April 19, 2020
1 Chemicals intended for industry, research and scientific use, namely, marbles, marked chemicals or chemical probes for detecting, separating and analysing macromolecular complexes, organic or inorganic compounds, biological ingredients, medicines and other substances that are biologically active in biological fluids such as blood, serum, plasma, urine, saliva, cell culture surnatant and cerebrospinal liquid, for medical, biological and veterinary purposes
5 Biological and chemical preparations and products, for medical or veterinary purposes, for detecting, separating and analysing materials within biological fluids such as blood, serum, plasma, urine, saliva, cell culture surnatant and cerebrospinal liquid, for medical, biological and veterinary purposes; medical preparations made from clinical materials and specimens for treating metabolic, cardiovascular, and neurodegenerative disorders; medical products derived from biological fluids, namely, antibodies and pharmaceutical or veterinary preparations for disease checking and testing purposes; biological products for medical diagnoses, namely, antibodies, recombinant proteins, nucleic acids and peptides for analysing biological fluids such as blood, serum, plasma, urine, saliva, cell culture surnatant and cerebrospinal liquid, for veterinary diagnosis and research purposes
42 Biomedical research and development services for biological, medical and veterinary products, particularly for treatment, prevention, medical diagnosis, and monitoring the clinical status and effectiveness of therapy for patients; research and development activities under contract in the fields of biotechnology, genomics, proteomics, gene expression and protein profiling, the discovery and development of medicines and the analysis of nucleic acid in the biomedical, forensics, environmental and food industries; analysis services provided by laboratories and care centres relating to testing and dosage of materials consisting of organic or inorganic compounds and biological ingredients within biological fluids such as blood, serum, plasma, urine, saliva, cell culture surnatant and cerebrospinal liquid; research and development activities under contract in the fields of medical technology, pharmaceuticals, biochemistry and genetics, scientific research services for medical purposes, namely, maintaining, testing, extracting and providing third parties with biological fluids such as blood, serum, plasma, urine, saliva, cell culture surnatant and cerebrospinal liquid and ingredients thereof, including chemical and biological products
Color is not claimed as a feature of the mark.
MEDICAL PRINT
May 10, 2021
Notification Of Effect Of Cancellation Of Intl Reg Mailed
May 10, 2021
Death Of International Registration
Jan 11, 2019
Total Invalidation Processed By The Ib
Dec 3, 2018
Total Invalidation Of Reg Ext Protection Sent To Ib
Dec 3, 2018
Invalidation Processed
Nov 16, 2018
Total Invalidation Of Reg Ext Protection Created
Mar 16, 2018
Cancelled Section 71
Oct 27, 2016
New Representative At Ib Received
Feb 26, 2016
New Representative At Ib Received
Apr 21, 2013
Final Decision Transaction Processed By Ib
Feb 28, 2013
Teas Change Of Correspondence Received
Mar 20, 2012
Final Disposition Notice Sent To Ib
Mar 20, 2012
Final Disposition Processed
Nov 9, 2011
Final Disposition Notice Created, To Be Sent To Ib
Aug 9, 2011
Registered-Principal Register
Jul 12, 2011
Notification Processed By Ib
May 24, 2011
Published For Opposition
May 4, 2011
Notification Of Possible Opposition Sent To Ib
May 4, 2011
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
May 4, 2011
Notice Of Publication
Apr 18, 2011
Law Office Publication Review Completed
Apr 18, 2011
Assigned To Lie
Apr 1, 2011
Approved For Pub - Principal Register
Mar 29, 2011
Teas/Email Correspondence Entered
Mar 28, 2011
Correspondence Received In Law Office
Mar 28, 2011
Teas Response To Office Action Received
Mar 4, 2011
Non-Final Action Mailed
Mar 4, 2011
Non-Final Action Written
Feb 22, 2011
Teas/Email Correspondence Entered
Feb 22, 2011
Correspondence Received In Law Office
Feb 22, 2011
Teas Response To Office Action Received
Nov 10, 2010
Refusal Processed By Ib
Oct 18, 2010
Non-Final Action Mailed - Refusal Sent To Ib
Oct 18, 2010
Refusal Processed By Mpu
Oct 16, 2010
Non-Final Action (Ib Refusal) Prepared For Review
Oct 15, 2010
Non-Final Action Written
Oct 13, 2010
Non-Final Action (Ib Refusal) Withdrawn For Review
Oct 13, 2010
Non-Final Action (Ib Refusal) Prepared For Review
Oct 12, 2010
Non-Final Action Written
Oct 12, 2010
Application Filing Receipt Mailed
Oct 8, 2010
Assigned To Examiner
Oct 8, 2010
New Application Office Supplied Data Entered In Tram
Oct 7, 2010
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
